Literature DB >> 7529239

Characterization of PCR-ribotyping for Burkholderia (Pseudomonas) cepacia.

S E Dasen1, J J LiPuma, J R Kostman, T L Stull.   

Abstract

Ribotyping, a method of genotyping bacterial isolates for epidemiologic study, uses rRNA as a probe to detect chromosomal restriction fragment length polymorphisms. Although ribotyping is accurate, its utility is limited by the labor and time necessary for Southern blot analysis. PCR-ribotyping uses PCR to amplify the 16S-23S intergenic spacer region of the bacterial rRNA operon. Length heterogeneity in the spacer region has previously been found to be useful as an alternative to standard ribotyping in a study of Burkholderia (Pseudomonas) cepacia. To further analyze the accuracy of PCR-ribotyping, three groups of previously characterized isolates of B. cepacia were investigated. PCR-ribotyping grouped 90 isolates recovered from seven well-defined epidemics into the correct outbreak group with a mean concordance of 93%. Both standard ribotyping and PCR-ribotyping separated 15 unrelated isolates into 14 types. In an analysis of 83 B. cepacia isolates from chronically colonized cystic fibrosis patients, the concordance of PCR-ribotyping with standard ribotyping ranged from 83 to 100%, with a mean of 98%. One isolate from a chronically colonized patient had a different type by standard ribotyping but was identical to the other isolates from this patient by PCR-ribotyping. Thus, PCR-ribotyping is a rapid and accurate method for typing B. cepacia and is less labor intensive than standard ribotyping.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7529239      PMCID: PMC264078          DOI: 10.1128/jcm.32.10.2422-2424.1994

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  16 in total

1.  Compilation of small ribosomal subunit RNA sequences.

Authors:  J M Neefs; Y Van de Peer; L Hendriks; R De Wachter
Journal:  Nucleic Acids Res       Date:  1990-04-25       Impact factor: 16.971

2.  A compilation of large subunit (23S-like) ribosomal RNA sequences presented in a secondary structure format.

Authors:  R R Gutell; M N Schnare; M W Gray
Journal:  Nucleic Acids Res       Date:  1990-04-25       Impact factor: 16.971

Review 3.  Mechanism and regulation of bacterial ribosomal RNA processing.

Authors:  A K Srivastava; D Schlessinger
Journal:  Annu Rev Microbiol       Date:  1990       Impact factor: 15.500

4.  A broad-spectrum probe for molecular epidemiology of bacteria: ribosomal RNA.

Authors:  T L Stull; J J LiPuma; T D Edlind
Journal:  J Infect Dis       Date:  1988-02       Impact factor: 5.226

5.  Pseudomonas cepacia typing systems: collaborative study to assess their potential in epidemiologic investigations.

Authors:  C S Rabkin; W R Jarvis; R L Anderson; J Govan; J Klinger; J LiPuma; W J Martone; H Monteil; C Richard; S Shigeta
Journal:  Rev Infect Dis       Date:  1989 Jul-Aug

6.  Physical map of the seven ribosomal RNA genes of Escherichia coli.

Authors:  I Boros; A Kiss; P Venetianer
Journal:  Nucleic Acids Res       Date:  1979       Impact factor: 16.971

7.  Ribotype analysis of Pseudomonas cepacia from cystic fibrosis treatment centers.

Authors:  J J LiPuma; J E Mortensen; S E Dasen; T D Edlind; D V Schidlow; J L Burns; T L Stull
Journal:  J Pediatr       Date:  1988-11       Impact factor: 4.406

8.  Ribotype stability of serial pulmonary isolates of Pseudomonas cepacia.

Authors:  J J LiPuma; M C Fisher; S E Dasen; J E Mortensen; T L Stull
Journal:  J Infect Dis       Date:  1991-07       Impact factor: 5.226

9.  Marked phenotypic variability in Pseudomonas cepacia isolated from a patient with cystic fibrosis.

Authors:  G Y Larsen; T L Stull; J L Burns
Journal:  J Clin Microbiol       Date:  1993-04       Impact factor: 5.948

10.  Person-to-person transmission of Pseudomonas cepacia between patients with cystic fibrosis.

Authors:  J J LiPuma; S E Dasen; D W Nielson; R C Stern; T L Stull
Journal:  Lancet       Date:  1990-11-03       Impact factor: 79.321

View more
  10 in total

1.  Phenotypic methods for determining genomovar status of the Burkholderia cepacia complex.

Authors:  D A Henry; E Mahenthiralingam; P Vandamme; T Coenye; D P Speert
Journal:  J Clin Microbiol       Date:  2001-03       Impact factor: 5.948

2.  Differentiation of Burkholderia species by PCR-restriction fragment length polymorphism analysis of the 16S rRNA gene and application to cystic fibrosis isolates.

Authors:  C Segonds; T Heulin; N Marty; G Chabanon
Journal:  J Clin Microbiol       Date:  1999-07       Impact factor: 5.948

Review 3.  The changing microbial epidemiology in cystic fibrosis.

Authors:  John J Lipuma
Journal:  Clin Microbiol Rev       Date:  2010-04       Impact factor: 26.132

4.  Genotypic analysis of Burkholderia cepacia isolates from 13 French cystic fibrosis centers.

Authors:  C Segonds; E Bingen; G Couetdic; S Mathy; N Brahimi; N Marty; P Plesiat; Y Michel-Briand; G Chabanon
Journal:  J Clin Microbiol       Date:  1997-08       Impact factor: 5.948

5.  Distinguishing species of the Burkholderia cepacia complex and Burkholderia gladioli by automated ribotyping.

Authors:  S Brisse; C M Verduin; D Milatovic; A Fluit; J Verhoef; S Laevens; P Vandamme; B Tümmler; H A Verbrugh; A van Belkum
Journal:  J Clin Microbiol       Date:  2000-05       Impact factor: 5.948

6.  Development of a multiple-locus variable-number tandem-repeat typing scheme for genetic fingerprinting of Burkholderia cenocepacia and application to nationwide epidemiological analysis.

Authors:  Christine Segonds; Michelle Thouverez; Antoine Barthe; Nadège Bossuet-Greif; Lenka Tisseyre; Patrick Plésiat; Gilles Vergnaud; Gérard Chabanon; Christine Pourcel
Journal:  J Clin Microbiol       Date:  2014-11-19       Impact factor: 5.948

Review 7.  Microbial pathogenesis in cystic fibrosis: mucoid Pseudomonas aeruginosa and Burkholderia cepacia.

Authors:  J R Govan; V Deretic
Journal:  Microbiol Rev       Date:  1996-09

8.  Comparison of different PCR approaches for characterization of Burkholderia (Pseudomonas) cepacia isolates.

Authors:  P Y Liu; Z Y Shi; Y J Lau; B S Hu; J M Shyr; W S Tsai; Y H Lin; C Y Tseng
Journal:  J Clin Microbiol       Date:  1995-12       Impact factor: 5.948

9.  Molecular epidemiology and phylogenetic analysis of Haemophilus parainfluenzae from chronic obstructive pulmonary disease exacerbations.

Authors:  A Privitera; L Licciardello; V Gianninò; A Agodi; G Rappazzo; G Nicoletti; S Stefani
Journal:  Eur J Epidemiol       Date:  1998-06       Impact factor: 8.082

Review 10.  Burkholderia cenocepacia Infections in Cystic Fibrosis Patients: Drug Resistance and Therapeutic Approaches.

Authors:  Viola C Scoffone; Laurent R Chiarelli; Gabriele Trespidi; Massimo Mentasti; Giovanna Riccardi; Silvia Buroni
Journal:  Front Microbiol       Date:  2017-08-22       Impact factor: 5.640

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.